Chou K-C, Jiang S-P (1974)
KLOW is not approved by the FDA, the EMA, or any comparable regulator for tissue repair, injury recovery, inflammation, or any other condition
Product Attributes Customization Available Certification ISO, CE Disinfection Disinfection Model NO
Archives of pharmacal research
Peptide Serums and creams work by triggering the body into thinking there is a topical skin injury
Common patient profiles include: Busy professionals who want the benefits of NAD+ without blocking out half a day for an IV session Frequent travelers who need portable, consistent NAD+ support across time zones Active adults over 35 who are noticing slower recovery, lower energy, or reduced mental sharpness Longevity-focused individuals incorporating NAD+ into a broader healthy-aging protocol Athletes using injections to support recovery and cellular repair between training blocks Post-illness recovery patients who want structured cellular support as they return to baseline Existing IV therapy patients who want to maintain benefits between clinic visits NAD+ injections are not for everyone, and a medical evaluation is always the first step
